TREATMENT ADHERENCE AND SOCIAL SUPPORT AMONG WOMEN WITH SCHIZOPHRENIA
-
Published:2021-04-15
Issue:
Volume:
Page:109-114
-
ISSN:
-
Container-title:PARIPEX INDIAN JOURNAL OF RESEARCH
-
language:en
-
Short-container-title:PIJR
Author:
Shivarudraiah Manjunatha1, Muralidhar Daliboina2
Affiliation:
1. Ph.D. Scholar in Psychiatric Social Work Department of Psychiatric Social Work, National Institute of Mental Health and Neuro Sciences, Bengaluru560029. 2. Retired Professor,Department of Psychiatric Social Work,National Institute of Mental Health and Neuro Sciences,Bengaluru-560029.
Abstract
Introduction:Women with schizophrenia face several challenges in terms of treatment adherence and social support.
Most people with schizophrenia in low- and middle-income countries like India receive minimal formal care and poor
social support,which further influence high non-adherence to medication.
Methodology: The descriptive research design has been adopted, and 60-women with schizophrenia were recruited
for the study from out-patient services of NIMHANS Hospital,Bengaluru.Subjects were selected by using a consecutive
sampling method. The researcher used a self-prepared checklist to assess Treatment Adherence among Women with
Schizophrenia (TAWS) and the Multidimensional Scale of Perceived Social Support (MSPSS) to collect the data.
Results:Adherence to treatment among women with schizophrenia has been influenced by many factors such as other
family activities are getting clash with the therapy,affordability,longer duration of treatment,accessibility,side effects of
medicine, social stigma, misconceptions about medicine, resistance to taking medication, negative attitude towards
treatment,repeated blood investigations and complex follow-ups,etc. Social Support from Family and significant others
are negatively correlated with Treatment adherence among women with Schizophrenia.
Conclusion: Poor adherence to treatment in patients with schizophrenia is a significant risk factor for poor outcomes,
including relapse, re-hospitalization, and suicide. A thorough understanding of the multiple factors that influence
adherence among women with schizophrenia would better deal with this problem.
Publisher
World Wide Journals
Reference12 articles.
1. Amador, X. F., Strauss, D. H., Yale, S. A., Flaum, M. M., Endicott, J., & Gorman, J. M. (1993). Assessment of insight in psychosis. Am J Psychiatry, 150(6), 873-879. 2. Andreasen, N. C., Flaum, M., Swayze, V. W., Tyrrell, G., & Arndt, S. (1990). Positive and negative symptoms in schizophrenia: A critical reappraisal. Archives of General Psychiatry, 47(7), 615-621. 3. Ceskova, E., & Prikryl, R. (2012). Importance of gender in the treatment of schizophrenia. The primary care companion for CNS disorders, 14(6). 4. Chandra, P. S., Herrman, H., Fisher, J., Kastrup, M., Niaz, U., Rondon, M., & Okasha, A. (2009). Contemporary Topics in Women’s Mental Health. Global Perspectives in a Changing Society. Chichester: John Wiley & Sons Ltd. 5. Collaborators, G. B. D. O. D., Bernabe, E., Marcenes, W., Hernandez, C. R., Bailey, J., Abreu, L. G., . . . Arefi, Z. (2020). Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: a systematic analysis for the global burden of disease 2017 study. Journal of dental research, 99(4), 362-373.
|
|